This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Long-term Outcome

H. Bryan Neel, III, MD, PhD; William F. Taylor, PhD

Arch Otolaryngol Head Neck Surg. 1989;115(11):1293-1303.

Abstract
• We report prognostic determinants and survival found after a long follow-up of 182 patients in North America in a prospective collaborative study. All patients were under observation since enrollment, and all were treated with modern equipment and techniques at major medical centers. Use of Cox regression methods identified five disease-related characteristics significantly associated with survival. These form the basis of the new staging system. A second system including antibody-dependent cellular cytotoxicity was developed because a high antibody-dependent cellular cytotoxicity titer correlated with good prognosis. The two new systems are better predictors of outcome than are the traditional staging systems. The unique World Health Organization 2 and 3 morphologic forms of nasopharyngeal carcinoma appear to be chronic diseases, because the risk of death does not level off with time, as it does for most other cancers.

(Arch Otolaryngol Head Neck Surg. 1989;115:1293-1303)

Author Affiliations
From the Department of Otorhinolaryngology (Dr Neel) and the Section of Biostatistics (Dr Taylor), Mayo Clinic and Mayo Foundation, Rochester, Minn.

Footnotes
Accepted for publication June 7, 1989.

Read before the American Society for Head and Neck Surgery, San Francisco, Calif, April 6, 1989.

Reprint requests to Mayo Clinic, 200 First St SW, Rochester, MN 55905 (Dr Neel).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical-Severity Staging System for Oropharyngeal Cancer: Five-Year Survival Rates
Pugliano et al.
Arch Otolaryngol Head Neck Surg 1997;123:1118-1124.
ABSTRACT  

Epstein-Barr Virus-Related Antibody: Changes in Titers After Therapy for Nasopharyngeal Carcinoma
Neel and Taylor
Arch Otolaryngol Head Neck Surg 1990;116:1287-1290.
ABSTRACT